BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18553183)

  • 1. Efficacy and safety of pregabalin in alcohol dependence.
    Martinotti G; Di Nicola M; Tedeschi D; Mazza M; Janiri L; Bria P
    Adv Ther; 2008 Jun; 25(6):608-18. PubMed ID: 18553183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.
    Martinotti G; Di Nicola M; Tedeschi D; Andreoli S; Reina D; Pomponi M; Mazza M; Romanelli R; Moroni N; De Filippis R; Di Giannantonio M; Pozzi G; Bria P; Janiri L
    J Psychopharmacol; 2010 Sep; 24(9):1367-74. PubMed ID: 19346279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome.
    Di Nicola M; Martinotti G; Tedeschi D; Frustaci A; Mazza M; Sarchiapone M; Pozzi G; Bria P; Janiri L
    Hum Psychopharmacol; 2010 Apr; 25(3):268-75. PubMed ID: 20373479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.
    Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L
    Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
    Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
    Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin for alcohol dependence: a critical review of the literature.
    Guglielmo R; Martinotti G; Clerici M; Janiri L
    Adv Ther; 2012 Nov; 29(11):947-57. PubMed ID: 23132700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L
    Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
    Myrick H; Anton R; Voronin K; Wang W; Henderson S
    Alcohol Clin Exp Res; 2007 Feb; 31(2):221-7. PubMed ID: 17250613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pregabalin for the reduction of opiate withdrawal symptoms].
    Kämmerer N; Lemenager T; Grosshans M; Kiefer F; Hermann D
    Psychiatr Prax; 2012 Oct; 39(7):351-2. PubMed ID: 22689280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.
    Martinotti G; Di Nicola M; Di Giannantonio M; Janiri L
    J Psychopharmacol; 2009 Mar; 23(2):123-9. PubMed ID: 18515460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
    Rubio G; Bobes J; Cervera G; Terán A; Pérez M; López-Gómez V; Rejas J
    Eur Addict Res; 2011; 17(5):262-70. PubMed ID: 21701173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin: From molecule to medicine.
    Kavoussi R
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin in clinical psychiatry and addiction: pros and cons.
    Martinotti G
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1243-5. PubMed ID: 22725618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin in the discontinuation of long-term benzodiazepines' use.
    Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN
    Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome.
    Allen R; Chen C; Soaita A; Wohlberg C; Knapp L; Peterson BT; García-Borreguero D; Miceli J
    Sleep Med; 2010 Jun; 11(6):512-9. PubMed ID: 20466589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients.
    Martinotti G; Di Nicola M; Romanelli R; Andreoli S; Pozzi G; Moroni N; Janiri L
    Hum Psychopharmacol; 2007 Apr; 22(3):149-56. PubMed ID: 17397097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment.
    Stock CJ; Carpenter L; Ying J; Greene T
    Ann Pharmacother; 2013; 47(7-8):961-9. PubMed ID: 23780805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.